- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05579496
Rebooting Infant Pain Care: Using Machine Learning and Skin-to-Skin Contact to Exponentially Improve Neonatal Intensive Care Unit Practice (BabyAIBabyCalm)
July 9, 2026 updated by: Rebecca Pillai Riddell, York University
To address the current limitations related to infant pain assessment in the NICU, our international team of knowledge users and health/natural science/engineering/social science researchers have come together to build a machine learning algorithm that will learn how to discriminate invasive and non-invasive distress.
Furthermore, to improve the use of current pain management practices, our team seeks to better understand the developmental mechanisms underlying skin-to-skin contact over time and factors that may influence its efficacy in mitigating pain responses in preterm infants.
This is an ongoing naturalistic observational study.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Unmanaged pain in hospitalized infants has serious long-term complications.
Existing infant pain assessment approaches demonstrate several key flaws (e.g., dependent on human cognitive capacity to simply combine data from multiple indicators into a total pain score, none have passed a critical discriminant validity test, bias introduced from human caregivers).
Thus, the complexity of preterm pain assessment necessitates a machine learning approach.
Our international team of knowledge users and health/natural science/engineering/social science researchers have come together to build a machine learning algorithm that will learn how to discriminate invasive and non-invasive distress.
Furthermore, better understanding how skin-to-skin contact works in caregiver-infant dyads and factors that influence the effectiveness of this pain management strategy is a critical step in improving infant pain care in NICUs.
Relatedly, the design and sample of our current study (acute pain paradigm while infant is either in skin-to-skin contact with the birthing parent or in the cot) allows us to not only test the influence of skin-to-skin contact vs. cot on preterm newborn pain responding, but also interrogate potential mechanisms underlying the effectiveness of skin-to-skin contact (i.e., cardiac regulation attunement between caregivers and their infants during the procedure; influence of birthing parent perceived stress given the particularly elevated stress levels of NICU parents).
A sample of 400 preterm infants (300 from Mount Sinai Hospital and 100 from University College London Hospital [UCLH]) and their birthing parents (if available) will be followed during a routine painful procedure (heel lance).
Pain indicators (facial grimacing [behavioural indicators], heart rate, respiration rate, oxygen saturation levels [physiologic indicators], brain electrical activity) during the painful procedure will be used to train the algorithm to discriminate between different types of distress (pain-related and non-pain related).
Heart rate and respiration rate, as well as maternal-reported perceived stress levels, will be collected from the birthing parent to examine factors impacting the effectiveness of skin-to-skin contact.
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rebecca Pillai Riddell, PhD
- Phone Number: ext. 20177 4167362100
- Email: rpr@yorku.ca
Study Contact Backup
- Name: Shah Vibhuti, MD
- Phone Number: 4165864816
- Email: Vibhuti.Shah@sinaihealth.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Recruiting
- Mount Sinai Hospital
-
Contact:
- Vibhuti Shah, MD
- Phone Number: 4165864816
- Email: Vibhuti.Shah@sinaihealth.ca
-
Contact:
- Carol Cheng, MSc
- Email: carol.cheng@sinaihealth.ca
-
-
-
-
No Province
-
London, No Province, United Kingdom, N1 2EP
- Recruiting
- University College London Hospital
-
Contact:
- Judith Meek, MD
- Phone Number: 020 3447 8094
- Email: judith.meek@nhs.net
-
Contact:
- Lorenzo Fabrizi, PhD
- Phone Number: Ext. 51888 02031081888
- Email: l.fabrizi@ucl.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 7 months (Child)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Preterm infants
Description
QUALITATIVE INTERVIEWS
Inclusion Criteria:
- Parents of a child currently in the NICU or
- Health professionals currently working in the NICU.
Exclusion Criteria:
*Participants who cannot communicate fluently in English
QUANTITITATIVE DATA CAPTURE (video, eeg, ecg, RR, SPo2)
Inclusion Criteria:
- Infants born between 25 0/7 weeks 32 6/7 weeks gestational age
- Infants who are within 8 weeks postnatal age
- Infants who are undergoing a routine heel lance
Exclusion Criteria:
- Infants with congenital malformations
- Infants receiving analgesics or sedatives at the time of study (aside from sucrose)
- Infants with history of perinatal hypoxia/ischemia at the time of study
- Infants with diaper rash or excoriated buttocks
- Parents who are not fluent in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Infants Hospitalized in the NICU
Infants born between 25 0/7 weeks 32 6/7 weeks gestational age, who are within 8 weeks postnatal age, and their caregiver (if available) and/or health professional will be recruited for qualitative interview.
Infants will participate in the study either in skin-to-skin contact with the birthing parent or in the cot if the parent is unable to participate.
If the baby participates in a skin-to-skin study, they will be transferred from the cot to skin-to-skin following EEG electrode placement and a 10-minute cot baseline recording.
Babies will be then exposed to a sham lance and a real lance while in skin-to-skin.
For cot studies, babies are kept in the cot for the whole study duration, and thus the sham lance and real lance will be conducted while they are in the cot receiving standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioural Correlate of Distress
Time Frame: NFCS-P coded in 1-5 minute epochs, over 2 hour surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
To be analyzed using machine learning via bedside videography: Facial Grimacing using Neonatal Facial Coding System (NFCS-P subset; Bucsea et al., 2022, 10.1097/j.pain.0000000000002798)
|
NFCS-P coded in 1-5 minute epochs, over 2 hour surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
|
Cortical Correlate of Distress
Time Frame: For 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
To be analyzed using machine learning via bedside monitoring: Continuous EEG data capture
|
For 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
|
Cardiac Correlates of Distress
Time Frame: Over 2 hours surrounding painful procedure (time locked to heel lance)
|
To be analyzed using machine learning via bedside monitoring: Heart Rate, Heart Rate Variability
|
Over 2 hours surrounding painful procedure (time locked to heel lance)
|
|
Oxygen Saturation Correlate of Distress
Time Frame: Over 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
To be analyzed using machine learning via bedside monitoring: amount of oxygen-carrying hemoglobin in the blood relative to the amount of hemoglobin not carrying oxygen
|
Over 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)
|
|
Respiration Rate Correlate of Distress
Time Frame: [Time Frame: Over 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)]
|
To be analyzed using machine learning via bedside monitoring: Respiratory patterns
|
[Time Frame: Over 2 hours surrounding painful procedure (time locked to heel lance; approximately 1 hour before to 1 hour after heel lance)]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Semi-Structured Interview
Time Frame: These interviews are occurring at the beginning of the study and will be qualitatively analyzed. They are not linked to infants whose data we are collecting primary outcomes.
|
Health Professionals and Caregivers will be asked about their thoughts on using AI for infant pain assessment
|
These interviews are occurring at the beginning of the study and will be qualitatively analyzed. They are not linked to infants whose data we are collecting primary outcomes.
|
|
Birthing Parent Heart Rate and Respiration Rate
Time Frame: [Time Frame: Over 1.5 hours surrounding painful procedure (time locked to heel lance)]
|
We will measure parent cardiac stress in order to control for the effect of the parent context on infant pain processing.
We will collect ECG data with 3 leads and a thin belt for respiration from the CNS monitor.
|
[Time Frame: Over 1.5 hours surrounding painful procedure (time locked to heel lance)]
|
|
Chart review of general health indicators and other NICU experiences (control as potential confounders), such as:
Time Frame: Extracted from participants' medical charts following study completion
|
|
Extracted from participants' medical charts following study completion
|
|
Chart Review of Cumulative Painful Procedures
Time Frame: Extracted from participants' medical charts following study completion
|
We will collect data on the cumulative exposure of painful and/or invasive procedures that the infant experienced since birth.
A published tool will be used to calculate total pain burden during their NICU stay (Laudiano-Dray et al., 2020; 10.1097/j.pain.0000000000001814).
|
Extracted from participants' medical charts following study completion
|
|
Parent Self-Report Questionnaires
Time Frame: Completed at the beginning of the study while EEG electrodes are being applied to the baby
|
Four questionnaires will be completed to understand the perspectives and experiences of birthing parents at time of study:
|
Completed at the beginning of the study while EEG electrodes are being applied to the baby
|
|
Detailed documentation of noxious and sham stimulation details: (Control for their influence on infant responses)
Time Frame: Documented following the study completion
|
|
Documented following the study completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rebecca Pillai Riddell, PhD, York University/Mount Sinai Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
March 1, 2031
Study Registration Dates
First Submitted
December 24, 2020
First Submitted That Met QC Criteria
October 11, 2022
First Posted (Actual)
October 13, 2022
Study Record Updates
Last Update Posted (Actual)
July 13, 2026
Last Update Submitted That Met QC Criteria
July 9, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-0252-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.